Chongqing Baiya Sanitary P: A Stagnant Show in a Volatile Market

The Shanghai‑based Chongqing Baiya Sanitary P (003006.SZ) has remained eerily flat—exactly 0 % over the 24‑hour window ending 08:51 AM Central Europe on Friday, 23 rd. For investors who crave drama, this lack of movement is a warning sign, not a triumph.

Current Snapshot

MetricValue
Current PriceCNH 23.76
Shares Outstanding429.6 million
Market CapitalisationCNH 1.4 bn
24‑Hour Trading VolumeCNH 1.2 bn
200‑Day Simple Moving AverageCNH 16.31
52‑Week HighCNH 24.98 (20 Oct 2026)
52‑Week LowCNH 12.51 (14 Jul 2026)
1‑Month Change+3.15 %

These numbers tell a single story: the stock is over‑valued relative to its moving average, and the recent uptick is insufficient to justify a 9‑point premium over the 200‑day average.

Comparative Performance

StockExchange% ChangeCurrent PriceMarket CapP/E
Cimc Enric (3899.HK)HKEX–2.55 %HKD 6.50HKD 1.8 bn10.49
China National Accord Medi (000028.SZ)SSE0 %CNH 20.65CNH 1.6 bn11.68
Cccc Design & Consulting G (600720.SS)SSE0 %CNH 4.99CNH 1.6 bn9.64
Jiangsu New Energy Develop (603693.SS)SSE0 %CNH 11.79CNH 1.6 bn32.65
Jiugui Liquor (000799.SZ)SSE0 %CNH 34.64CNH 1.6 bn–

Note: Only Cimc Enric shows a negative drift, reflecting a broader sectoral slide that Chongqing Baiya has failed to capitalize on.

What the Numbers Hide

  • Liquidity Concerns: A flat 24‑hour performance coupled with a high market cap relative to volume suggests limited investor appetite.
  • Valuation Gap: Trading at CNH 23.76 while the 200‑day SMA is CNH 16.31 indicates a 46 % premium.
  • Volatility Gap: The 52‑week high of CNH 24.98 is a narrow margin above the current price, raising the specter of a sharp pullback.
  • Peer Comparison: None of the listed peers have achieved meaningful gains; only Cimc Enric has moved, and it fell.

Bottom Line

Chongqing Baiya Sanitary P is sitting on a thin ice‑layer of optimism. The 3.15 % month‑over‑month rise is a blip, not a breakout. Investors should weigh the risk of a sudden reversal against the company’s lackluster performance and the broader market’s cautious stance. Unless there is a catalyst—such as a breakthrough product line or a strategic partnership—the stock’s trajectory remains uncertain and potentially perilous.